- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Big Green Snowflakes
Norwegian Pharmaceuticals & Biotech Big Green Snowflakes
Results
17
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
17 companies
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.10
7D
-1.3%
1Y
-17.2%
Norda
Market Cap: NOK 415.7m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 81.00
7D
0%
1Y
95.2%
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 25.50
7D
1.6%
1Y
45.1%
Navamedic
Market Cap: NOK 379.7m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.50
7D
-1.4%
1Y
-28.6%
Photocure
Market Cap: NOK 1.5b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 57.40
7D
-4.0%
1Y
8.7%
Nykode Therapeutics
Market Cap: NOK 516.9m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.58
7D
5.5%
1Y
-66.0%
Lytix Biopharma
Market Cap: NOK 491.5m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 7.20
7D
-6.3%
1Y
-2.2%
EXACT Therapeutics
Market Cap: NOK 120.2m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 1.90
7D
-15.2%
1Y
-63.5%
Zelluna
Market Cap: NOK 251.6m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 12.30
7D
-3.1%
1Y
n/a
Arctic Bioscience
Market Cap: NOK 100.7m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.75
7D
-5.1%
1Y
-72.6%
Thor Medical
Market Cap: NOK 1.3b
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 3.60
7D
-23.1%
1Y
253.1%
BerGenBio
Market Cap: NOK 47.5m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory disease in Norway.
BGBIO
NOK 1.22
7D
2.4%
1Y
-87.8%
PCI Biotech Holding
Market Cap: NOK 13.1m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.35
7D
-13.4%
1Y
-81.2%
SoftOx Solutions
Market Cap: NOK 187.7m
Operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.083
7D
-0.5%
1Y
337.9%
Oncoinvent
Market Cap: NOK 151.5m
A clinical stage company, develops radiopharmaceutical therapies against cancer.
ONCIN
NOK 1.55
7D
8.1%
1Y
n/a
Hofseth BioCare
Market Cap: NOK 719.4m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.75
7D
-2.8%
1Y
1.7%
Circio Holding
Market Cap: NOK 66.4m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 0.61
7D
-3.0%
1Y
-17.1%